Your source of breaking information about Dutasteride also known as Avodart, Avolve, GI198745, GG745 or Duagen.
dutasteride duagen avodart avolve is an independent clearinghouse for information about Dutasteride and is not associated or affiliated with GlaxoSmithKline or the Glaxo Group Limited. Avolve, Avodart and Duagen are registered trademarks of Glaxo Group Limited.  

What is Dutasteride

The Latest News

Dutasteride Studies

Dutasteride Safety Profile

FDA Approval Documents

Dutasteride Results

If you are interested in getting more information via email about the availability of Avodart please enter your email address below

hair loss MPB Dutasteridedutastiride avolve duagen
Dutasteride Research Studies
Published Scientific Studies
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.
Urology 2002 Sep;60(3):434
Managing benign prostatic hyperplasia.
Am Fam Physician 2002 Jul 1;66(1):77-84
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.
World J Urol 2002 Apr;19(6):413-25
Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.
Biochem Pharmacol 2001 Oct 1;62(7):933-42
Mass spectral fragmentation reactions of a therapeutic 4-azasteroid and related compounds.
J Am Soc Mass Spectrom 2001 Apr;12(4):385-98
Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II.
Pharmacogenetics 2000 Jul;10(5):407-13
Dihydrotestosterone and the concept of 5 alpha-reductase inhibition in human benign prostatic hyperplasia.
Eur Urol 2000 Apr;37(4):367-80
Validation of a population pharmacokinetic/pharmacodynamic model for 5 alpha-reductase inhibitors.
Eur J Pharm Sci 1999 Aug;8(4):291-9
The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination.
Br J Clin Pharmacol 1999 Jan;47(1):53-8
A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride.
Clin Pharmacol Ther 1998 Dec;64(6):636-47
Discovery and development of GG745, a potent inhibitor of both isozymes of 5 alpha-reductase.
Pharm Biotechnol 1998;11:393-422
Unique Preclinical Characteristics of GG745, A Potent Dual Inhibitor of 5AR
J Pharmacol Exp
Ther. 1997 Sep;282(3):1496-502.
lowers DHT and promotes hair regrowth
Glaxo sells Avodart also know as Dutasteride   Avolve Avodart  GI198745  Duagen
  Copyright © 2002 Interactive Marketing Group - All Rights Reserved - email: [email protected]